Sandoz
sandoz.comTotal trials
139
Active
3
Phase 3
36
Total enrollment
22,863
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 6 of 6 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| CYB704 | — | — | — | — | — | 1 | |
| Ocrevus-EU | — | — | — | — | — | 1 | |
| Ocrevus-US | — | — | — | — | — | 1 | |
| GME751 | — | — | — | — | 2 | ||
| Keytruda - EU | — | — | — | — | — | 1 | |
| Keytruda - US | — | — | — | — | — | 1 |
Next readouts
- 2026-06
- 2026-11
Top conditions
- Depression13
- Healthy11
- HIV Infections10
- Hypertension8
- Cytopenias6
- Rheumatoid Arthritis6
- Anemia5
- Breast Cancer4
Frequently asked questions about Sandoz
- How many clinical trials does Sandoz have on ClinicalTrials.gov?
- Sandoz is listed as the lead sponsor on 139 clinical trials in ClinicalTrials.gov, 3 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Sandoz's trials are in Phase 3?
- 36 of Sandoz's trials are in Phase 3, spread across 6 active drug programs.
- What therapeutic areas does Sandoz focus on?
- Sandoz's most-studied conditions on ClinicalTrials.gov are Depression, Healthy, HIV Infections, Hypertension, Cytopenias.
- When are Sandoz's next clinical trial readouts?
- Sandoz has 2 upcoming primary-completion readouts tracked here; the soonest is “A PK Study to Compare GME751 (Proposed Pembrolizumab Biosimilar) and US-licensed and EU-authorized Keytruda® in Participants With Stage II and III Melanoma”, expected around 2026-06.